| Filed On | Filing |
|---|---|
| 27 Aug 2024 | CUE HEALTH INC. |
| 27 Aug 2024 |
Form 4: Tarsadia Capital, Llc, 10% owner and 8 others
Sold 10,684,791 shares ($1.07K) · Sold 4,298,453 shares · Sold 3,319,000 shares |
| 28 Jun 2024 | 25-NSE |
| 28 May 2024 |
8-K: Termination of a Material Definitive Agreement; Bankruptcy or Receivership +3 more
San Diego, CA – May 28, 2024 – Cue Health Inc. (“Cue” or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the Distric... |
| 21 May 2024 |
Form 4/A: Javed Aasim, Chief Financial Officer
Gave up 13,327 shares to cover exercise price or tax ($3.33K) |
| 17 May 2024 | SC 13D/A |
| 16 May 2024 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more
On May 12, 2024, Ayub Khattak provided notice of his resignation from the Board of Directors (the “Board”) of Cue Health Inc. ("the Company") and all committees thereof, to be effective as of May 14, 2024. Mr. Khattak’s resignation is no... |
| 16 May 2024 | NT 10-Q |
| 01 May 2024 |
8-K: Costs Associated with Exit or Disposal Activities
On May 1, 2024, Cue Health Inc. (“Cue” or the “Company”) implemented a new cost reduction plan (the “CRP”). Management, with the oversight and guidance of the Company’s board of directors, determined to implement the CRP following a revi... |
| 24 Apr 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
On April 19, 2024, Aasim Javed, Chief Financial Officer of Cue Health Inc. (the “Company”) tendered his resignation as Chief Financial Officer to be effective as of May 13, 2024 (the “Effective Date”). The Company is appreciative of the ... |
| 22 Apr 2024 | ARS |
| 22 Apr 2024 | DEF 14A |
| 12 Apr 2024 | PRE 14A |
| 09 Apr 2024 | 8-A12B/A |
| 09 Apr 2024 |
8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +1 more
This Amendment No. 1 to the Preferred Stock Rights Agreement (this “Amendment”) is dated as of April 8, 2024 (the “Effective Date”), and amends the Preferred Stock Rights Agreement, dated as of September 21, 2023 (the “Rights Agreement”)... |
| 29 Mar 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
On March 26, 2024, Cue Health Inc. (the “Company”) entered into a separation agreement and release with Mr. Khattak (the “Khattak Separation Agreement”) in connection with his departure from the Company on March 19, 2024. The circumstanc... |
| 27 Mar 2024 |
Form 4: Sever Clint, Chief Executive Officer
Gave up 20,456 shares to cover exercise price or tax ($3.89K) |
| 20 Mar 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
Board Appoints Two Strategic Advisors Who Bring Significant Industry Expertise |
| 13 Mar 2024 | S-8 |
| 13 Mar 2024 | 10-K |
Loading...